9D9 is a frequently applied anti-CTLA-4 agent within immune research , particularly relating to cancer immunotherapy . Primarily, developed for inhibiting CTLA-4 activity , 9D9 successfully https://www.targetmol.com/compound/anti_mouse_ctla_4_antibody_9d9